E-viri
Recenzirano
Odprti dostop
-
GIRALT, S; STADTMAUER, E. A; MERLINI, G; SAN MIGUEL, J; LUDWIG, H; HAJEK, R; JAGANNATH, S; BLADE, J; LONIAL, S; DIMOPOULOS, M. A; EINSELE, H; BARLOGIE, B; HAROUSSEAU, J. L; ANDERSON, K. C; GERTZ, M; ATTAL, M; TOSI, P; SONNEVELD, P; BOCCADORO, M; MORGAN, G; SEZER, O; MATEOS, M. V; CAVO, M; PALUMBO, A; JOSHUA, D; TURESSON, I; CHEN, W; SHIMIZU, K; POWLES, R; RICHARDSON, P. G; NIESVIZKY, R; RAJKUMAR, S. V; DURIE, Bgm; BENSINGER, W; COMENZO, R. L; KUMAR, S; MUNSHI, N. C; DISPENZIERI, A; KYLE, R
Leukemia, 10/2009, Letnik: 23, Številka: 10Journal Article, Conference Proceeding
Multiple myeloma is the most common indication for high-dose chemotherapy with autologous stem cell support (ASCT) in North America today. Stem cell procurement for ASCT has most commonly been performed with stem cell mobilization using colony-stimulating factors with or without prior chemotherapy. The target CD34+ cell dose to be collected as well as the number of apheresis performed varies throughout the country, but a minimum of 2 million CD34+ cells/kg has been traditionally used for the support of one cycle of high-dose therapy. With the advent of plerixafor (AMD3100) (a novel stem cell mobilization agent), it is pertinent to review the current status of stem cell mobilization for myeloma as well as the role of autologous stem cell transplantation in this disease. On June 1, 2008, a panel of experts was convened by the International Myeloma Foundation to address issues regarding stem cell mobilization and autologous transplantation in myeloma in the context of new therapies. The panel was asked to discuss a variety of issues regarding stem cell collection and transplantation in myeloma especially with the arrival of plerixafor. Herein, is a summary of their deliberations and conclusions.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.